Correlation Between ANI Pharmaceuticals and Evolus
Can any of the company-specific risk be diversified away by investing in both ANI Pharmaceuticals and Evolus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ANI Pharmaceuticals and Evolus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ANI Pharmaceuticals and Evolus Inc, you can compare the effects of market volatilities on ANI Pharmaceuticals and Evolus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ANI Pharmaceuticals with a short position of Evolus. Check out your portfolio center. Please also check ongoing floating volatility patterns of ANI Pharmaceuticals and Evolus.
Diversification Opportunities for ANI Pharmaceuticals and Evolus
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between ANI and Evolus is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding ANI Pharmaceuticals and Evolus Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evolus Inc and ANI Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ANI Pharmaceuticals are associated (or correlated) with Evolus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evolus Inc has no effect on the direction of ANI Pharmaceuticals i.e., ANI Pharmaceuticals and Evolus go up and down completely randomly.
Pair Corralation between ANI Pharmaceuticals and Evolus
Given the investment horizon of 90 days ANI Pharmaceuticals is expected to under-perform the Evolus. But the stock apears to be less risky and, when comparing its historical volatility, ANI Pharmaceuticals is 1.25 times less risky than Evolus. The stock trades about -0.03 of its potential returns per unit of risk. The Evolus Inc is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 1,263 in Evolus Inc on August 24, 2024 and sell it today you would earn a total of 41.00 from holding Evolus Inc or generate 3.25% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
ANI Pharmaceuticals vs. Evolus Inc
Performance |
| Timeline |
| ANI Pharmaceuticals |
| Evolus Inc |
ANI Pharmaceuticals and Evolus Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ANI Pharmaceuticals and Evolus
The main advantage of trading using opposite ANI Pharmaceuticals and Evolus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ANI Pharmaceuticals position performs unexpectedly, Evolus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evolus will offset losses from the drop in Evolus' long position.| ANI Pharmaceuticals vs. Phibro Animal Health | ANI Pharmaceuticals vs. Prestige Brand Holdings | ANI Pharmaceuticals vs. Alkermes Plc | ANI Pharmaceuticals vs. Dr Reddys Laboratories |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |